TY - JOUR
T1 - Expert statements on the standard of care in critically ill adult patients with atypical haemolytic uraemic syndrome
AU - Azoulay, Elie
AU - Knoebl, Paul
AU - Garnacho-Montero, José
AU - Rusinova, Katerina
AU - Galstian, Gennadii
AU - Eggimann, Philippe
AU - Abroug, Fekri
AU - Benoit, Dominique
AU - von Bergwelt-Baildon, Michael
AU - Wendon, Julia
AU - Scully, Marie
PY - 2017/4/23
Y1 - 2017/4/23
N2 - Background Atypical haemolytic uraemic syndrome (aHUS) presents similarly to thrombotic thrombocytopenic purpura (TTP), and other causes or conditions with thrombotic microangiopathy (TMA) such as DIC or sepsis. Similarity in clinical presentation may hinder diagnosis and optimal treatment selection in the urgent setting in the ICU. However, there is currently no consensus on the diagnosis or treatment of aHUS for ICU specialists. This review aims to summarise available data on the diagnosis and treatment strategies of aHUS in the ICU in order to enhance the understanding of aHUS diagnosis and outcomes in patients managed in the ICU. Methods A review of the recent literature (January 2009 – March 2016) was performed to select the most relevant articles for ICU physicians. Results Based on the paucity of adult aHUS cases overall and within the ICU, no specific recommendations could be formally graded for the critical care setting. However, the expert panel recognises a core set of skills required by intensivists for diagnosing and managing patients with aHUS: recognising thrombotic microangiopathies, differentiating aHUS from related conditions, recognising involvement of other organ systems, understanding the pathophysiology of aHUS, knowing the diagnostic workup and relevant outcomes in critically ill aHUS patients, and knowing the standard of care for patients with aHUS based on available data and guidelines. Conclusions Managing critically ill patients with aHUS requires basic skills that, in the absence of sufficient data from patients treated within the ICU, can be gleaned from an increasingly relevant literature outside the ICU. More data on critically ill patients with aHUS are needed to validate these conclusions within the ICU setting.
AB - Background Atypical haemolytic uraemic syndrome (aHUS) presents similarly to thrombotic thrombocytopenic purpura (TTP), and other causes or conditions with thrombotic microangiopathy (TMA) such as DIC or sepsis. Similarity in clinical presentation may hinder diagnosis and optimal treatment selection in the urgent setting in the ICU. However, there is currently no consensus on the diagnosis or treatment of aHUS for ICU specialists. This review aims to summarise available data on the diagnosis and treatment strategies of aHUS in the ICU in order to enhance the understanding of aHUS diagnosis and outcomes in patients managed in the ICU. Methods A review of the recent literature (January 2009 – March 2016) was performed to select the most relevant articles for ICU physicians. Results Based on the paucity of adult aHUS cases overall and within the ICU, no specific recommendations could be formally graded for the critical care setting. However, the expert panel recognises a core set of skills required by intensivists for diagnosing and managing patients with aHUS: recognising thrombotic microangiopathies, differentiating aHUS from related conditions, recognising involvement of other organ systems, understanding the pathophysiology of aHUS, knowing the diagnostic workup and relevant outcomes in critically ill aHUS patients, and knowing the standard of care for patients with aHUS based on available data and guidelines. Conclusions Managing critically ill patients with aHUS requires basic skills that, in the absence of sufficient data from patients treated within the ICU, can be gleaned from an increasingly relevant literature outside the ICU. More data on critically ill patients with aHUS are needed to validate these conclusions within the ICU setting.
KW - Atypical haemolytic uraemic syndrome
KW - thrombocytopenia
KW - thrombotic microangiopathy
KW - organ failure
KW - plasma exchange
KW - eculizumab
U2 - 10.1016/j.chest.2017.03.055
DO - 10.1016/j.chest.2017.03.055
M3 - Article
SN - 0012-3692
JO - Chest
JF - Chest
ER -